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 794 
One Sentence Summary: Comprehensive heritability analysis of brain phenotypes demonstrates a 795 
clear role for common genetic variation across neurological and psychiatric disorders and 796 
behavioral-cognitive traits, with substantial overlaps in genetic risk. 797 
Abstract: Disorders of the brain can exhibit considerable epidemiological comorbidity and share 798 
symptoms, provoking debate about their etiologic overlap. We quantified the genetic sharing of 25 brain 799 
disorders from genome-wide association studies of 215,683 patients and 657,164 controls, and their 800 
relationship to 17 phenotypes from 1,191,588 individuals. Psychiatric disorders share common variant risk, 801 
while neurological disorders appear more distinct from one another and from the psychiatric disorders. We 802 
also identify significant sharing between disorders and a number of brain phenotypes, including cognitive 803 
measures. Simulations were used to explore how power, diagnostic misclassification and phenotypic 804 
heterogeneity affect genetic correlations. These results highlight the importance of common genetic 805 
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variation as a risk factor for brain disorders and the value of heritability-based methods in understanding 806 
their etiology. 807 
Main Text:  808 
The classification of brain disorders has evolved over the past century, reflecting the 809 
medical and scientific communities’ assessments of the presumed root causes of clinical 810 
phenomena such as behavioral change, loss of motor function, spontaneous movements or 811 
alterations of consciousness. Directly observable phenomena (such as the presence of emboli, 812 
protein tangles, or unusual electrical activity patterns) generally define and separate neurological 813 
disorders from psychiatric disorders(1). Understanding the genetic underpinnings and categorical 814 
distinctions between brain disorders may be helpful in informing the search for the biological 815 
pathways underlying their pathophysiology(2, 3). 816 
In general, brain disorders (excepting those caused by trauma, infection, or cancer) show 817 
substantial heritability from twin and family studies(4). Epidemiological and twin studies have 818 
explored patterns of phenotypic overlaps(5-7), and comorbidity has been reported for many pairs 819 
of disorders, including bipolar disorder-migraine(8), stroke-major depressive disorder(MDD)(9), 820 
epilepsy-autism spectrum disorders (ASD), and epilepsy-attention deficit hyperactivity disorder 821 
(ADHD)(10, 11). Furthermore, there may also be direct etiological links, as e.g. mutations in the 822 
same ion channel genes confer pleiotropic risk for multiple distinct brain phenotypes(12-14). 823 
Genome-wide association studies (GWAS) have demonstrated that individual common risk 824 
variants can overlap across traditional diagnostic boundaries(15, 16), and that disorders like 825 
schizophrenia, MDD, and bipolar disorder can have genetic correlations(17).  826 
GWAS have also demonstrated that common genetic variation contributes to the 827 
heritability of brain disorders. Generally, this occurs via the combination of many common 828 
variants, each with a small individual effect, with examples in Alzheimer’s disease(18), bipolar 829 
disorder(19), migraine(20), Parkinson’s disease(21), and schizophrenia(22). In addition to locus 830 
discovery, the degree of distinctiveness(23) across neurological and psychiatric phenotypes can be 831 
evaluated with the introduction of novel heritability-based methods(24) and sufficiently large 832 
sample sizes for robust heritability analysis. These analyses can shed light on the nature of these 833 
diagnostic boundaries and explore the extent of shared common variant genetic influences.  834 
 835 
Study design 836 
The Brainstorm consortium is a collaboration among GWAS meta-analysis consortia of 25 837 
disorders (see Table 1), to perform a comprehensive heritability and correlation analysis of brain 838 
disorders. We included meta-analyses of any common brain disorders for which we could identify 839 
a GWAS meta-analysis consortium of sufficient size for heritability analysis. The total study 840 
sample consists of 215,683 cases of different brain disorders and 657,164 controls (Table 1), and 841 
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includes at least one representative of most ICD-10 blocks covering mental and behavioral 842 
disorders and diseases of the central nervous system. Also included are 1,191,588 samples for 13 843 
“behavioral-cognitive” phenotypes (n=744,486) traditionally viewed as brain-related, and four 844 
“additional” phenotypes (n=447,102) selected to represent known, well-delineated etiological 845 
processes (immune disorders [Crohn’s disease], vascular disease [coronary artery disease] and 846 
anthropomorphic measures [height and BMI]; Table 2).  847 
GWAS summary statistics for the 42 disorders and phenotypes were centralized and 848 
underwent uniform quality control and processing(25)(83). We used European-only meta-analyses 849 
for each disorder to avoid potential bias arising from ancestry differences, generating new meta-850 
analyses for those datasets where the original sample sets had diverse ancestries. Clinically 851 
relevant subtypes from three disorders (epilepsy, migraine, and ischemic stroke) were also 852 
included; in these cases, the subtype datasets are parts of the top-level dataset (Table 1).  853 
We have developed a heritability estimation method, linkage disequilibrium score 854 
regression (LDSC)(24), which was used to calculate heritability estimates and correlations, as well 855 
as to estimate their statistical significance from block jack-knife-based standard errors. More 856 
formally, we estimate the common variant heritability (h2g) of each disorder, defined as the 857 
proportion of phenotypic variance in the population that could theoretically be explained by an 858 
optimal linear predictor formed using the additive effects of all common (minor allele frequency 859 
> 5%) autosomal SNPs. The genetic correlation for a pair of phenotypes is then defined as the 860 
correlation between their optimal genetic predictors. Heritability for binary disorders and 861 
phenotypes was transformed to the liability scale. We further performed a weighted-least squares 862 
regression analysis to evaluate whether differences relating to study makeup (such as sample size) 863 
were correlated with the magnitude of the correlation estimates. Finally, we performed a 864 
heritability partitioning analysis(83) using stratified LD score regression to examine whether the 865 
observed heritability for the disorders or phenotypes was enriched into any of the tissue-specific 866 
regulatory regions or functional category partitions of the genome, using ten top-level tissue-type 867 
and 53 functional partitions from Finucane et al.(26). Finally, simulated phenotype data was 868 
generated under different scenarios by permuting 120,267 genotyped individuals from the UK 869 
Biobank(25) to evaluate power and aid in interpreting the results(83). 870 
 871 
Heritability estimates and their error sources 872 
We observed a similar range of heritability estimates among the disorders and the 873 
behavioral-cognitive phenotypes (Fig. S1A-B and Table S1, S2), roughly in line with previously 874 
reported estimates from smaller datasets (Table S3). Three ischemic stroke subtypes 875 
(cardioembolic, large-vessel disease, and small-vessel disease) as well as the “agreeableness” 876 
personality measure from NEO Five-Factor Inventory(27) had insufficient evidence of additive 877 
heritability for robust analysis and thus were excluded from further analysis(25). The only 878 
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observed correlation between heritability estimates and factors relating to study makeup (Table 879 
S4; Fig. S1C-F) was a modest correlation between age of onset of the disorder and heritability, 880 
suggesting that early-onset brain disorders tend to be more heritable. Since some of our 881 
interpretation of the results depends on lack of observed correlation, we explored the behavior of 882 
observed correlation versus power (Fig. S2A), standard errors (Fig. S2B) and the individual results 883 
(Fig. S2C and D) to identify where we can be reasonably robust in claiming lack of correlation.  884 
The common variant heritability estimates for the psychiatric and neurological disorders 885 
were generally somewhat lower than previously reported estimates from common variants (Table 886 
S5). A similar pattern was observed for the behavioral-cognitive traits, when comparing estimates 887 
reported here with those previously reported in smaller sample sizes(28) with the exception of 888 
‘openness’, ‘neuroticism’, and ‘never/ever smoked’, suggesting that some attenuation in 889 
heritability is observed when moving to larger sample sizes. Measures related to cognitive ability, 890 
such as childhood cognitive performance (heritability estimate of 0.19, [SE 0.03]) and years of 891 
education (heritability estimate of 0.30 [SE 0.01]), yielded estimates that were more consistent 892 
with previous estimates of the heritability of intelligence(29, 30), suggesting that the cognitive 893 
measures may be less prone to phenotypic measurement error and/or have a higher heritability 894 
overall than the personality measures.  895 
These heritability estimates should be interpreted somewhat cautiously, as they reflect the 896 
phenotype ascertained in each study, and will be deflated in the presence of diagnostic 897 
heterogeneity, ascertainment errors or unusual contributions of high-impact rare variants. To 898 
evaluate potential sources of these differences, we explored three approaches(83): evaluating the 899 
differences in real data, simulation work (Table S5), and quantifying the magnitude of effect for 900 
potentially implied misclassification (Table S6).  901 
In comparison to heritability estimates obtained using twin and family data, the more 902 
diverse selection and survival biases in the underlying data may attenuate the heritability estimates 903 
and correlations, as might increased within-disorder heterogeneity introduced by the larger meta-904 
analyses. A related explanation for the lower estimates of heritability may be that increasing 905 
sample sizes have led to expanded inclusion criteria, meaning that less severely affected cases with 906 
a lower overall burden of risk factors (both genetic and environmental) might be included, which 907 
in turn would attenuate estimates of heritability. However, the successful identification of genome-908 
wide significant loci suggests that these larger samples are nevertheless very useful for genetic 909 
studies, and the simulation results suggest that this has at most a limited effect on estimated genetic 910 
correlations (Fig S9). Even so, some of the pairs of phenotypes included here lack sufficient power 911 
for robust estimation of genetic correlations. Moreover, our analyses only examine the properties 912 
of common variant contributions and extending these analyses to include the effects of rare 913 
variants may further inform the extent of genetic overlap. For example, epilepsy and ASD show 914 
substantial overlap in genetic risk from de novo loss of functional mutations(31), in contrast to the 915 
limited common variant sharing observed in this study. This may suggest that the rare and common 916 
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variant contributions to genetic overlap may behave differently and that incorporating the two 917 
variant classes into a single analysis may provide further insight into brain disorder pathogenesis.  918 
To address the possibility of methodological differences contributing to the differences in 919 
the estimates and although LDSC and REML have previously been shown to yield similar 920 
estimates from the same data(24), we performed our own comparison in Alzheimer’s disease(32) 921 
(selected based on data availability). In Alzheimer’s disease, the previously published heritability 922 
estimate (0.24 [SE 0.03]) is significantly different from the estimate in the current study (0.13 [SE 923 
0.02]). These differences may reflect implicit heterogeneity in a much larger case collection used 924 
in the current study (effective sample size 10,494 vs. 46,669) and the potential reasons listed above, 925 
but they could also be due to methodological variability (most of the previous estimated listed in 926 
Table S3 are estimated with a different methodology). To evaluate this, we applied the same 927 
analytical process used in this paper to the summary statistics of the GERAD cohort (3,941 cases 928 
and 7,848 controls) from the Alzheimer’s disease meta-analysis, where the previous heritability 929 
estimate was calculated. There, we obtained a heritability estimate of 0.25 [SE 0.04], which agrees 930 
closely with the published estimate of 0.24 [SE 0.03], suggesting that the different estimates may 931 
reflect differences between datasets rather than methodological variability. 932 
 933 
Correlations among brain disorders 934 
We observed widespread sharing across psychiatric disorders (Fig. 1 and S3) by expanding 935 
the number of brain disorder pairs studied beyond those previously reported(17), but similar 936 
sharing was not observed among neurological disorders. Among the psychiatric disorders, 937 
schizophrenia showed significant genetic correlation with most of the psychiatric disorders, while 938 
MDD was positively (though not necessarily significantly) correlated with every other disorder 939 
tested. Further, schizophrenia, bipolar disorder, anxiety disorders, MDD, and ADHD each showed 940 
a high degree of correlation to the four others (average genetic correlation [rg]=0.40; Table S7A). 941 
Anorexia nervosa, obsessive-compulsive disorder (OCD), and schizophrenia also demonstrated 942 
significant sharing amongst themselves (Fig. 1). However, the common variant risk of both ASD 943 
and Tourette Syndrome (TS) appear to be distinct from other psychiatric disorders, although with 944 
significant correlation between TS, OCD, and MDD, as well as between ASD and schizophrenia. 945 
Similarly, post-traumatic stress disorder (PTSD) showed no significant correlation with any of the 946 
other psychiatric phenotypes (though some correlation to ADHD and MDD was observed). The 947 
modest power of the ASD, PTSD, and TS meta-analyses, however, limits the strength of this 948 
conclusion (Fig. S2C).  949 
Neurological disorders showed a more limited extent of genetic correlation than the 950 
psychiatric disorders (Fig. 2 and S4, Table S7A), suggesting greater diagnostic specificity and/or 951 
more distinct etiologies. Parkinson’s disease, Alzheimer’s disease, generalized epilepsy, and 952 
multiple sclerosis showed little to no correlation with other brain disorders. The highest degree of 953 
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genetic correlation among the neurological disorders was observed with focal epilepsy (average rg 954 
=0.46, excluding the other epilepsy datasets), though none were significant, reflecting the 955 
relatively modest power of the current focal epilepsy meta-analysis (Fig. S2C). However, the 956 
modest heritability and the broad pattern of sharing observed for focal epilepsy may be consistent 957 
with heterogeneity and potentially even diagnostic misclassification across a range of neurological 958 
conditions.  959 
In the cross-category correlation analysis, the observed pattern is consistent with limited 960 
sharing across the included neurological and psychiatric disorders (Fig. 3; average rg=0.03). The 961 
only significant cross-category correlations were with migraine, suggesting it may share some of 962 
its genetic architecture with psychiatric disorders; migraine-ADHD (rg=0.26, p=8.81 x 10
-8), 963 
migraine-TS (rg=0.19, p=1.80 x 10
-5), and migraine-MDD (rg=0.32, p=1.42 x 10
-22 for all 964 
migraine, rg=0.23, p=5.23 x 10
-5 for migraine without aura, rg=0.28, p=1.00 x 10
-4 for migraine 965 
with aura). 966 
We observed several significant genetic correlations between the behavioral-cognitive or 967 
additional phenotypes and brain disorders (Fig. 4 and Table S7B). Results for cognitive traits were 968 
dichotomous among psychiatric phenotypes (Fig. S5A), with ADHD, anxiety disorders, MDD, 969 
and TS showing negative correlations to the cognitive measures and anorexia nervosa, ASD, 970 
bipolar disorder and OCD showing positive correlations. Schizophrenia showed more mixed 971 
results, with significantly negative correlation to intelligence but positive correlation to years of 972 
education. Among neurological phenotypes (Fig. S5B), the correlations were either negative or 973 
null, with Alzheimer’s disease, epilepsy, ICH, ischemic stroke, early-onset stroke, and migraine 974 
showing significantly negative correlations. Correlations between college attainment and years of 975 
education with bipolar disorder(24), Alzheimer’s disease, and schizophrenia have been previously 976 
reported(33)).  977 
Among the personality and symptom measures, significant positive correlations were 978 
observed between neuroticism and anorexia nervosa, anxiety disorders, migraine, migraine 979 
without aura, MDD, OCD, schizophrenia, and TS (Fig. S6A and S6B; replicating previously 980 
reported correlations with MDD and schizophrenia(34)); between depressive symptoms and 981 
ADHD, anxiety disorder, bipolar disorder, MDD, and schizophrenia; and between subjective well-982 
being and anxiety disorder, bipolar disorder, and MDD. For smoking-related measures, the only 983 
significant genetic correlations were between never/ever smoked and MDD (rg=0.33, p=3.10 x 10
-984 
11) as well as ADHD (rg=0.37, p=3.15 x 10
-6).  985 
Among the additional phenotypes, the two examples of disorders with well-defined 986 
etiologies had different results. Crohn’s disease, representing immunological pathophysiology, 987 
showed no correlation with any of the study phenotypes, while the phenotype representing vascular 988 
pathophysiology (coronary artery disease) showed significant correlation to MDD (rg=0.19, 989 
p=8.71 x 10-5) as well as the two stroke-related phenotypes (rg=0.69, p=2.47 x 10
-6 to ischemic 990 
stroke and rg=0.86, p=2.26 x 10
-5 to early-onset stroke), suggesting shared genetic effects across 991 
 21 
 
these phenotypes. Significant correlations were also observed for BMI, which was positively 992 
correlated with ADHD and MDD, and negatively correlated with anorexia nervosa (as previously 993 
reported with a different dataset(24)) and schizophrenia. 994 
Our enrichment analysis (Fig. S7, Tables S8-12) demonstrated significant heritability 995 
enrichments between central nervous system (CNS) and generalized epilepsy, MDD, TS, college 996 
attainment, intelligence, neuroticism, never/ever smoked); depressive symptoms and 997 
adrenal/pancreatic cells and tissues, as well as between hematopoetic cells (category which 998 
includes immune system cells) and multiple sclerosis (Figs. S7A and S7B, Tables S8 and S9). We 999 
replicate the reported (CNS) enrichment for schizophrenia, bipolar disorder, and years of education 1000 
(Tables S8, S9), and observe the reported enrichments for BMI (CNS), years of education (CNS), 1001 
height (connective tissues and bone, cardiovascular system and other), and Crohn’s disease 1002 
(hematopoietic cells) from the same datasets (Fig. S7C, D)(26). We further note that the psychiatric 1003 
disorders with large numbers of identified GWAS loci (bipolar disorder, MDD, and schizophrenia) 1004 
and migraine, which was the only cross-correlated neurological disorder, show enrichment to 1005 
conserved regions (Tables S10 and S12), while the other neurological disorders with similar 1006 
numbers of loci (MS, Alzheimer’s, and Parkinson’s diseases) do not (Fig. S7A, B). Enrichment to 1007 
conserved regions was also observed to neuroticism, intelligence and college attainment and to 1008 
H3K9ac peaks for BMI (Tables S11 and S12). 1009 
 1010 
Discussion 1011 
By integrating and analyzing the genome-wide association summary statistic data from 1012 
consortia of 25 brain disorders, we find that psychiatric disorders broadly share a considerable 1013 
portion of their common variant genetic risk, especially across schizophrenia, MDD, bipolar 1014 
disorder, anxiety disorder, and ADHD, while neurological disorders are more genetically distinct. 1015 
Across categories, psychiatric and neurologic disorders share relatively little common genetic risk, 1016 
suggesting that multiple different and largely independently regulated etiological pathways may 1017 
give rise to similar clinical manifestations (e.g., psychosis, which manifests in both 1018 
schizophrenia(35) and Alzheimer’s disease(36)). Except for migraine, which appears to share 1019 
some genetic architecture with psychiatric disorders, the existing clinical delineation between 1020 
neurology and psychiatry is corroborated at the level of common variant risk for the studied 1021 
disorders.  1022 
We performed some exploratory analyses based on the observed results to address concerns 1023 
about diagnostic overlap and misclassification, which are particularly relevant to psychiatric 1024 
disorders due to their spectral nature. Given that the broad and continuous nature of psychiatric 1025 
disorder spectra has long been clinically recognized(37-39) and that patients can, in small numbers, 1026 
progress from one diagnosis to another(40), we evaluated to what extent this kind of diagnostic 1027 
overlap could explain the observed correlations. Genetic correlation could arise if, for example, 1028 
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patients progress through multiple diagnoses over their lifetime, or if some specific diagnostic 1029 
boundaries between phenotype pairs are particularly porous to misclassification (Table S5). While 1030 
it would a priori appear unlikely to observe large-scale misclassification of migraine as 1031 
schizophrenia, for example, there may be more substantial misclassification between particular 1032 
psychiatric disorders, consistent with the clinical controversies in classification. Previous work(41) 1033 
suggests that substantial misclassification (on the order of 15-30%, depending on whether it is uni- 1034 
or bi-directional) is required to introduce false levels of genetic correlation. We found that the 1035 
observed levels of correlation are unlikely to appear in the absence of underlying genetic 1036 
correlation (Table S6), as it is apparent that a very high degree of misclassification (up to 79%) 1037 
would be required to produce the observed correlations in the absence of any true genetic 1038 
correlation, and that reasonably expected misclassification would have limited impact on the 1039 
observed rg (Fig. S8). Therefore, these results suggest true sharing of a substantial fraction of the 1040 
common variant genetic architecture among psychiatric disorders as well as between behavioral-1041 
cognitive measures and brain disorders. We also performed large-scale simulations to explore the 1042 
effect of sample size, polygenicity and degree of correlation on power to detect significant 1043 
correlations. First, we established that the observed heritability of the simulated misclassified traits 1044 
in the UK Biobank data behaves as would be theoretically expected (Fig. S9A), and that the effects 1045 
on observed correlation (Fig. S9B and S9C) are in line with the estimates from family data(41). 1046 
Reasonably low levels of misclassification or changes to the exact level of heritability appear 1047 
unlikely to induce significant correlations, as observed in the power analysis (Fig. S10), though a 1048 
lower observed heritability caused by substantial misclassification (Fig. S9A) will decrease the 1049 
power to estimate true genetic overlap. 1050 
The high degree of genetic correlation among the psychiatric disorders adds further 1051 
evidence that current clinical diagnostics do not reflect specific genetic etiology for these 1052 
disorders, and that genetic risk factors for psychiatric disorders do not respect clinical diagnostic 1053 
boundaries. Rather, this suggests a more interconnected genetic etiology, in contrast to 1054 
neurological disorders, and underscores the need to refine psychiatric diagnostics. This study may 1055 
provide important ‘scaffolding’ to support a framework for investigating mental disorders, 1056 
incorporating many levels of information to understand basic dimensions of brain function.  1057 
The observed positive genetic correlations are consistent with a few hypothetical scenarios. 1058 
For example, it may reflect the existence of some portion of common genetic risk factors 1059 
conferring risks for multiple psychiatric disorders and where other distinct additional factors, both 1060 
genetic and non-genetic, contribute to the eventual clinical presentation. The presence of 1061 
significant genetic correlation may also reflect the phenotypic overlap between any two disorders; 1062 
for example, the sharing between schizophrenia and ADHD might reflect underlying difficulties 1063 
in executive functioning, which are well-established in both disorders(42), and that the shared risk 1064 
arises from a partial capture of its shared genetic component. Similarly, we might speculate that a 1065 
shared mechanism underlying cognitive biases may extend from overvalued ideas to delusions 1066 
(ranging from anorexia nervosa and OCD to schizophrenia), and that this heritable intermediate 1067 
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trait confers pleiotropic risk to multiple outcomes. This kind of latent variable could give rise to 1068 
the observed genetic correlation between disorders due to the shared portion of variation affecting 1069 
that variable. While a combination of these is likely, more genome-wide significant loci are needed 1070 
to evaluate these overlaps at the locus level. 1071 
Conversely, the low correlations observed across neurological disorders suggest that the 1072 
current classification reflects relatively specific genetic etiologies, although the limited sample 1073 
size for some of these disorders and lack of inclusion of disorders conceived as “circuit-based” in 1074 
the literature, such as restless legs syndrome, sleep disorders and possibly essential tremor, 1075 
constrains the full generalizability of this conclusion. Degenerative disorders (such as Alzheimer’s 1076 
and Parkinson’s diseases) would not be expected a priori to share their polygenic risk profiles with 1077 
a neuro-immunological disorder (like multiple sclerosis) or neurovascular disorder (like ischemic 1078 
stroke). Similarly, we see limited evidence for the reported co-morbidity between migraine with 1079 
aura and ischemic stroke(43) (rg=0.29, p=0.099); however, the standard errors of this comparison 1080 
are too high to draw strong conclusions. At the disorder subtype level, migraine with and without 1081 
aura (rg=0.48, p=1.79 x 10
-5) shows substantial genetic correlation, while focal and generalized 1082 
epilepsy (rg=0.16, p=0.388) show much less.  1083 
The few significant correlations across neurology and psychiatry, namely between 1084 
migraine and ADHD, MDD, and TS, suggest modest shared etiological overlap across the 1085 
neurology/psychiatry distinction. The co-morbidity of migraine with MDD, TS and ADHD has 1086 
been previously reported in epidemiological studies(44-47), while in contrast, the previously 1087 
reported co-morbidity between migraine and bipolar disorder seen in epidemiological studies (48) 1088 
was not reflected in our estimate of genetic correlation (rg=-0.03, p=0.406). 1089 
Several phenotypes show only very low-level correlations with any of the other disorders 1090 
and phenotypes studied here, despite large sample size and robust evidence for heritability, 1091 
suggesting their common variant genetic risk may largely be unique. Alzheimer’s disease, 1092 
Parkinson’s disease, and multiple sclerosis show extremely limited sharing with the other 1093 
phenotypes and with each other. Neuroinflammation has been implicated in the pathophysiology 1094 
of each of these conditions(49-51), as it has for migraine(52) and many psychiatric conditions, 1095 
including schizophrenia(53), but no considerable shared heritability was observed with either of 1096 
those conditions nor with Crohn’s disease, nor did we observe enrichment for immune-related 1097 
tissues in the functional partitioning (Fig. S7) as for Crohn’s disease. While this does not preclude 1098 
the sharing of individual neuroinflammatory mechanisms in these disorders, the large-scale lack 1099 
of shared common variant genetic influences supports the distinctiveness of disorder etiology. 1100 
Further, we only observed significant enrichment of heritability for immunological cells and 1101 
tissues in multiple sclerosis, showing that inflammation-specific regulatory marks in the genome 1102 
do not show overall enrichment for common variant risk for either Alzheimer’s or Parkinson’s 1103 
diseases (though this does not preclude the effects of specific, non-polygenic neuroinflammatory 1104 
mechanisms(54)). Among psychiatric disorders, ASD and TS showed a similar absence of 1105 
correlation with other disorders, although this could reflect small sample sizes. 1106 
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Analysis of the Big Five personality measures suggest that the current sample sizes may 1107 
be large enough for correlation testing; neuroticism, which has by far the largest sample size, 1108 
shows several significant correlations. Most significant of these was to MDD (rg=0.737, p=5.04 x 1109 
10-96), providing evidence for the link between these phenotypes, as reported for polygenic risk 1110 
scores(55) and twin studies(56, 57); as well as other psychiatric disorders (Fig. 4, Table S7B). The 1111 
correlation between MDD and anxiety disorders, with a similar pattern of correlation and the 1112 
dimensional measures of depressive symptoms, subjective well-being, and neuroticism suggests 1113 
that they all tag a similar underlying etiology. The significant correlation between coronary artery 1114 
disease and MDD supports the link between MDD and CAD(58), while the observed correlation 1115 
between ADHD and smoking initiation (rg=0.374, p=3.15 x 10
-6) is consistent with the 1116 
epidemiological evidence of overlap(59) and findings from twin studies(60). 1117 
For the neurological disorders, five (Alzheimer’s disease, intracerebral hemorrhage, 1118 
ischemic and early-onset stroke, and migraine) showed significant negative genetic correlation to 1119 
the cognitive measures, while a two (epilepsy and focal epilepsy) showed moderate negative 1120 
genetic correlation (Fig. S5). For Alzheimer’s disease, poor cognitive performance in early life has 1121 
been linked to increased risk for developing the disorder(61), but to our knowledge no such 1122 
connection has been reported for other phenotypes. Among the psychiatric disorders, ADHD, 1123 
anxiety disorders and MDD show a significant negative correlation to cognitive and education 1124 
attainment measures, while the remaining five of the eight psychiatric disorders (anorexia nervosa, 1125 
ASD, bipolar disorder, OCD, and schizophrenia) showed significant positive genetic correlation 1126 
with one or more cognitive measures. These results suggest the existence of a link between 1127 
cognitive performance in early life and the genetic risk for both psychiatric and neurological brain 1128 
disorders. The basis of the genetic correlations between education, cognition and brain disorders 1129 
may have a variety of root causes including indexing performance differences on the basis of 1130 
behavioral dysregulation (e.g., ADHD relating to attentional problems during cognitive tests) or 1131 
may reflect ascertainment biases in certain disorders conditional on impaired cognition (e.g., 1132 
individuals with lower cognitive reserve being more rapidly identified for Alzheimer’s disease), 1133 
but the results could also suggest a direct link between the underlying etiologies.  1134 
BMI shows significant positive genetic correlation to ADHD, consistent with a meta-1135 
analysis linking ADHD to obesity(62), and negative genetic correlation with anorexia nervosa, 1136 
OCD, and schizophrenia. This is consistent with evidence for enrichment of BMI heritability in 1137 
CNS tissues(26) that suggest neuronal involvement(63); this may also provide a partial genetic 1138 
explanation for lower BMI in anorexia nervosa patients even after recovery(64). Given that no 1139 
strong correlations were observed between BMI and any of the neurological phenotypes, it may 1140 
be that BMI’s brain-specific genetic architecture is more closely related to behavioral phenotypes. 1141 
Ischemic stroke and BMI show surprisingly little genetic correlation in this analysis (rg=0.07, 1142 
p=0.26), suggesting that although BMI is a risk factor for stroke(65), there is little evidence for 1143 
shared common genetic effects. These analyses also suggest that the reported reduced rates of 1144 
cardiovascular disease in individuals with histories of anorexia nervosa(66, 67) are more likely 1145 
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due to BMI-related secondary effects. The limited evidence of genetic correlation of anorexia 1146 
nervosa with intracerebral hemorrhage, ischemic stroke, early-onset stroke and coronary artery 1147 
disease suggest that any lower cardiovascular mortality is more likely due to direct BMI-related 1148 
effects rather than genetic risk variants.  1149 
The genetic correlation results presented here indicate that the clinical boundaries for the 1150 
studied psychiatric phenotypes do not reflect distinct underlying pathogenic processes. This 1151 
suggests that genetically informed analyses may provide a basis for restructuring of psychiatric 1152 
nosology, consistent with twin and family-based results. In contrast, neurological disorders show 1153 
greater genetic specificity, and although it is important to emphasize that while some brain 1154 
disorders are under-represented here, our results demonstrate the limited evidence for widespread 1155 
common genetic risk sharing between psychiatric and neurological disorders. However, we 1156 
provide strong evidence that both psychiatric and neurological disorders show robust correlations 1157 
with cognitive and personality measures, suggesting new avenues for follow-up studies. Further 1158 
study is needed to evaluate whether overlapping genetic contributions to psychiatric pathology 1159 
may influence treatment choices. Ultimately, such developments give hope to reducing diagnostic 1160 
heterogeneity and eventually improving the diagnostics and treatment of psychiatric disorders.  1161 
Materials and Methods 1162 
We collected GWAS meta-analysis summary statistics for 25 brain disorders and 17 other 1163 
phenotypes from various consortia, and where necessary generated new, non-sex-stratified 1164 
European-cohorts-only versions of the meta-analyses(25). All datasets underwent uniform quality 1165 
control (83). For each trait, using the linkage disequilibrium score (LDSC) framework(24), the 1166 
total additive common SNP heritability present in the summary statistics (h2g) was estimated by 1167 
regressing the association χ2 statistic of a SNP against the total amount of common genetic 1168 
variation tagged by that SNP, for all SNPs. Genetic correlations (rg; i.e., the genome-wide average 1169 
shared genetic risk) for pairs of phenotypes were estimated by regressing the product of Z-score 1170 
for each phenotype and for each SNP, instead of the χ2 statistic. Significance was assessed by 1171 
Bonferroni multiple testing correction via estimating the number of independent brain disorder 1172 
phenotypes via matrix decomposition (83). Functional and partitioning analyses for the GWAS 1173 
datasets were also performed using LDSC. Power analyses and simulation work to aid in 1174 
interpretation of the results were conducted using genotype data from the UK Biobank Resource 1175 
(83). 1176 
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Figure 1. Genetic correlations across psychiatric phenotypes.  1500 
 1501 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance 1502 
(LDSC), with significant correlations filling each box completely. Asterisks indicate genetic correlations which are 1503 
significantly different from zero after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – 1504 
autism spectrum disorder; MDD – major depressive disorder; OCD – obsessive-compulsive disorder; PTSD – post-1505 
traumatic stress disorder.  1506 
 35 
 
Figure 2. Genetic correlations across neurological phenotypes.  1507 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance (LDSC), 1508 
with significant correlations filling each box completely. Asterisks indicate genetic correlations which are 1509 
significantly different from zero after Bonferroni correction. Some phenotypes have substantial overlaps (see Table 1510 
1), e.g. all cases of generalized epilepsy are also cases of epilepsy. Asterisks indicate significant genetic correlation 1511 
after multiple testing correction. ICH – intracerebral hemorrhage. 1512 
  1513 
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Figure 3. Genetic correlations across neurological and psychiatric phenotypes.  1514 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance (LDSC), 1515 
with significant correlations filling each box completely. Asterisks indicate genetic correlations which are 1516 
significantly different from zero after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – 1517 
autism spectrum disorder; ICH – intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-1518 
compulsive disorder; PTSD – post-traumatic stress disorder.  1519 
 37 
 
Figure 4. Genetic correlations across brain disorders and behavioral-cognitive phenotypes.  1520 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance (LDSC), 1521 
with significant correlations filling each box completely. Asterisks indicate genetic correlations which are 1522 
significantly different from zero after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – 1523 
autism spectrum disorder; ICH – intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-1524 
compulsive disorder; PTSD – post-traumatic stress disorder; BMI –body-mass index.  1525 
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Table 1. Brain disorder phenotypes used in the Brainstorm project.  1526 
 1527 
Indented phenotypes are part of a larger whole, e.g. the epilepsy study contains the samples from both focal epilepsy 1528 
and generalized epilepsy; sample counts for such overlaps are shown in gray. ADHD – attention deficit hyperactivity 1529 
disorder; OCD – obsessive-compulsive disorder. ‘Anxiety disorders’ refers to a meta-analysis of five subtypes 1530 
(generalized anxiety disorder, panic disorder, social phobia, agoraphobia, and specific phobias). References are 1531 
listed in Table S1 and data availability in Table S13. 1532 
  1533 
Psychiatric disorders Neurological disorders
Disorder Source Cases Controls Disorder Source Cases Controls
ADHD PGC-ADD2 12,645 84,435 Alzheimer's disease IGAP 17,008 37,154
Anorexia nervosa PGC-ED 3,495 11,105 Epilepsy ILAE 7,779 20,439
Anxiety disorders ANGST 5,761 11,765    Focal epilepsy " 4,601 17,985
Autism spectrum disorder PGC-AUT 6,197 7,377    Generalized epilepsy " 2,525 16,244
Bipolar disorder PGC-BIP2 20,352 31,358 Intracerebral hemorrhage ISGC 1,545 1,481
Major depressive disorder PGC-MDD2 16,823 25,632 Ischemic stroke METASTROKE 10,307 19,326
OCD PGC-OCDTS 2,936 7,279     Cardioembolic stroke " 1,859 17,708
PTSD PGC-PTSD 2,424 7,113     Early-onset stroke " 3,274 11,012
Schizophrenia PGC-SCZ2 33,640 43,456     Large-vessel disease " 1,817 17,708
Tourette Syndrome PGC-OCDTS 4,220 8,994     Small-vessel disease " 1,349 17,708
Migraine IHGC 59,673 316,078
   Migraine with aura " 6,332 142,817
   Migraine without aura " 8,348 136,758
Multiple sclerosis IMSGC 5,545 12,153
Parkinson's disease IPDGC 5,333 12,019
Total psychiatric 108,493 238,514 Total neurologic 107,190 418,650
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Table 2. Behavioral-cognitive and additional phenotypes used in the study.  1534 
  1535 
Indented phenotypes are part of a larger whole, e.g. samples in the college attainment analysis are a subset of those 1536 
in the analysis for years of education; sample counts for such overlaps are shown in gray. (d) – dichotomous 1537 
phenotype, (q) – quantitative phenotype. BMI – body-mass index. References and phenotype definitions are listed in 1538 
Table S2, and data availability in Table S13.  1539 
  1540 
Phenotype Source Samples
Behavioral-cognitive phenotypes
Cognitive
   Years of education (q) SSGAC 293,723
   College attainment (d) " 120,917
   Cognitive performance (q) " 17,989
   Intelligence (d) CTG 78,308
Personality measures
   Subjective well-being SSGAC 298,420
   Depressive symptoms " 161,460
   Neuroticism (q) " 170,911
   Extraversion (q) GPC 63,030
   Agreeableness (q) " 17,375
   Conscientiousness (q) " 17,375
   Openness (q) " 17,375
Smoking-related
   Never/ever smoked (d) TAG 74,035
   Cigarettes per day (q) TAG 38,617
Additional phenotypes
   BMI (q) GIANT 339,224
   Height (q) " 253,288
   Coronary artery disease (d) Cardiogram 86,995
   Crohn's disease (d) IIBDGC 20,883
Total 1,124,048
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Introduction 
Disorders of the brain can exhibit considerable epidemiological comorbidity and share symptoms, provoking debate about their 
etiologic overlap. However, detailed study of phenotypes with different ages of onset, severity and presentation presents a 
considerable challenge. Recently developed heritability methods allow us to accurately measure correlation of genome-wide 
common variant risk between two phenotypes from pools of different individuals, to understand how connected they, or at 
least their genetic risks, are on the genomic level. We quantified the degree of overlap for genetic risk factors of 25 common 
brain disorders, based on genome-wide association data for 215,683 patients and 657,164 controls, as well as 17 phenotypes 
from a total of 1,191,588 individuals. 
Rationale 
The classification of brain disorders has evolved over the last century, reflecting the medical and scientific communities’ 
assessments of the presumed root causes of clinical phenomena such as behavioral change, loss of motor function, or 
alterations of consciousness. Directly observable phenomena (such as the presence of emboli, protein tangles, or unusual 
electrical activity patterns) generally define and separate neurological disorders from psychiatric disorders. Understanding the 
genetic underpinnings and categorical distinctions for brain disorders and related phenotypes may inform the search for their 
biological mechanisms. 
Results 
Common variant risk for psychiatric disorders was shown to correlate significantly, especially between ADHD, bipolar disorder, 
major depressive disorder (MDD) and schizophrenia. In contrast, neurological disorders appear more distinct from one another 
and from the psychiatric disorders, except for migraine, which was significantly correlated to ADHD, MDD and Tourette 
Syndrome. We demonstrate that the personality trait neuroticism in the general population is significantly correlated with 
almost every psychiatric disorder and migraine. We also identify significant sharing between disorders and early life cognitive 
measures in the general population (e.g. years of education and college attainment), demonstrating positive correlation with 
several psychiatric disorders (e.g. anorexia nervosa and bipolar disorder) and negative correlation with several neurological 
phenotypes (e.g. Alzheimer’s disease and ischemic stroke), even though the latter are considered to result from specific 
processes that occur later in life. Extensive simulations were also performed to inform how power, diagnostic misclassification 
and phenotypic heterogeneity influence genetic correlations. 
Conclusion 
The high degree of genetic correlation among many of the psychiatric disorders adds further evidence that the current clinical 
boundaries among them do not reflect distinct underlying pathogenic processes, at least on the genetic level. This suggests a 
deeply interconnected nature, in contrast to neurological disorders, and underscores the need to refine psychiatric diagnostics. 
Genetically informed analyses may provide important ‘scaffolding’ to support such restructuring of psychiatric nosology, which 
likely requires incorporating many levels of information. In contrast, we find limited evidence for widespread common genetic 
risk sharing among neurological disorders or across neurological and psychiatric disorders. We show that both psychiatric and 
neurological disorders have robust correlations with cognitive and personality measures. Further study is needed to evaluate 
whether overlapping genetic contributions to psychiatric pathology may influence treatment choices. Ultimately, such 
developments give hope to reducing heterogeneity and eventually improving the diagnosis and treatment of psychiatric 
disorders. 
 
 
 
 
 Figure Caption 
Subsection of genetic risk correlations among brain disorders and quantitative phenotypes.  
Heritability analysis of brain disorders points to pervasive sharing of genetic risk among psychiatric 
disorders, largely absent among neurological disorders, but present from both groups to neuro-cognitive 
quantitative phenotypes. Only significant correlations shown. Color and line solidity indicate direction 
and magnitude of correlation, respectively. ADHD – attention deficit hyperactivity disorder; MDD – 
major depressive disorder. 




